Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Smart & Biggar’ returned 2,497 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    PMPRB News: "Significant Changes" To Be Made To Draft Pricing Guidelines

    On April 2, 2020, the Patented Medicine Prices Review Board (PMPRB) published a message from the Chairperson regarding the results of its consultation on the draft Guidelines operationalizing the...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Releases New Draft Guidelines For Comment

    Following its Phase 2 Consultations, on December 19, 2025, the Patented Medicine Prices Review Board (PMPRB) released its new Draft Guidelines and accompanying Overview.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Restricted Drugs Now Possible Through The Special Access Program

    On January 5, 2022, amendments came into force amending the Food and Drug Regulations to allow practitioners to request access to restricted drugs through the Special Access Program (SAP)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Government Introduces Bill C-4 To Implement Changes Required Under USMCA

    On January 29, 2020, Bill C-4, which addresses some of the changes required under the Agreement between Canada, the U.S. and Mexico (USMCA), was introduced in the House of...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Leave To Appeal To Supreme Court Of Canada Denied To Philip Morris In Trademark Dispute

    The Supreme Court of Canada denied leave to appeal to Philip Morris from the Federal Court of Appeal's decision in Marlboro Canada Limited, Imperial Tobacco Canada Limited v. Phillips Morris Products S.A., Rothmans, Benson & Hedges Inc., 2012 FCA 201.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Legal Issues Regarding Oral Histories

    Jill Tonus contributed the sole legal paper, Legal Issues Regarding Oral Histories. Jill's paper can be found on page 98 of the reader.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Patent Protection For Stem Cells - Expanding Opportunities

    Therapeutic applications of stem cells are central to the promise of regenerative medicine. An increasing number of stem cell therapies are being approved for clinical use and by some estimates
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Podcast Series With Louis-Pierre Gravelle In Collaboration With ISEQ

    We are proud to announce a new podcast series with Louis-Pierre Gravelle of B&P in collaboration with ISEQ to demystify and explore the intellectual property (IP)...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Retailers Seek Superior Court Of Québec Declaration Against OQLF In French Language Signage Dispute

    On October 9, 2012, six retailers, BEST BUY, COSTCO, GAP, OLD NAVY, GUESS? and WAL-MART, filed a motion in the Superior Court of Québec seeking a declaratory judgement against the Office québécoise de la langue française (OQLF) that the use of their trademarks on signage, without a French descriptor, is compliant with the Charter of the French Language (the Charter) and its regulations.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Denies Pharmascience Leave To Appeal Decision Upholding The Validity Of Two Patents Relating To ELIQUIS

    On March 30, 2023, the Supreme Court of Canada dismissed Pharmascience's application for leave to appeal (Docket No. 40400) a decision of the Federal Court of Appeal (FCA) upholding the validity...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Native Advertising (A.K.A. Sponsored Content) Gets Noticed… This Article Is Sponsored By Bereskin & Parr

    The US Federal Trade Commission is taking aim at native advertising and sponsored content.
    CanadaMedia, Telecoms, IT, Entertainment
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Court Of Appeal Affirms Award Of Legal Costs Of $6.5 Million In Patent Infringement Case

    The cost award appears to be the largest reported award that the Federal Court has ever granted in an action for patent infringement.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    ICANN Reveals New gTLD Applications

    Today, ICANN announced the list of applied-for new generic top level domain names ("gTLDs").
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Section 8 And Other Claims Following Failed PMNOC Regulations Proceedings

    Apotex's initial patent hold was revoked and later re-instated, but only after the PMNOC proceedings had been resolved.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Dow Prevails Over Nova In Polymer Patent Suit

    The Dow Chemical Company ("Dow") has prevailed in a Canadian patent infringement suit against Nova Chemicals Corporation ("Nova") relating to Nova's manufacture and sale of its SURPASS film-grade polymers.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    2017-2018 Statistical Report For PMNOC Regulations And Data Protection

    The Report includes information regarding trends in listing on the Patent Register and the Register of Innovative Drugs, as well as related court activity.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Getting Your Patent Application Into The Fast Lane: Canada's Patent Prosecution Highway

    The success of the program has resulted in foreign patent office participation being extended.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Amendments To Food And Drug Regulations (Exports), Natural Health Products Regulations (Labelling)

    The Federal Government has published the following proposed amending regulations in Part 1 of the Canada Gazette...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Court Dismisses Motion For A Fifth Generic To Be Added To Rivaroxaban Trial Of Common Issues Under PMNOC Regulations

    The Federal Court had previously allowed a concurrent trial on common invalidity issues in actions under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Publishes Notice Of Consultation For Proposed Amendments To The Medical Devices Regulations

    On January 7, 2022, Health Canada issued a notice of consultation for proposed amendments to the Medical Devices Regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Showing 221–240 of 2497 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics